Literature DB >> 32731224

Endoscopic Endonasal Approaches for Anterior Skull Base Meningiomas.

Alexandre B Todeschini1, André Beer-Furlan2, Brad Otto1,3, Daniel M Prevedello1,3, Ricardo L Carrau4,5.   

Abstract

Anterior skull base meningiomas are a diverse group of tumors that involve different locations. The role of the expanded endoscopic transnasal approach in the management of anterior cranial fossa meningiomas has significantly changed over the past 2 decades. Patient selection is paramount to benefit from the advantages of endoscopic transnasal surgery such as direct access to ventral skull base lesions avoiding brain and brainstem retraction, early de-vascularization, removal of bone infiltrated by tumor, near-field magnification, better surgical field illumination, and minimal manipulation of neurovascular structures. Here we discuss some of the main limitations and advantages of the endoscopic transnasal approach related to patient selection, including nuances of their management, discussing preoperative imaging and planning, the surgical approach, and future perspectives in the treatment of these tumors.
© 2020 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2020        PMID: 32731224     DOI: 10.1159/000457931

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  3 in total

Review 1.  Modern endoscopic skull base neurosurgery.

Authors:  Rafael Martinez-Perez; Luis C Requena; Ricardo L Carrau; Daniel M Prevedello
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Letter to the Editor: "Olfactory nerve sparing technique for anterior skull base meningiomas: How I do it".

Authors:  Francesco Doglietto; Marco Maria Fontanella; Edoardo Agosti; A Yohan Alexander
Journal:  Acta Neurochir (Wien)       Date:  2022-01-30       Impact factor: 2.216

3.  Evolution in endoscopic endonasal approach for the management of hypothalamic-pituitary region metastasis: A single-institution experience.

Authors:  Cinzia Baiano; Teresa Somma; Raduan Ahmed Franca; Marianna Di Costanzo; Maria Rosaria Scala; Pasquale Cretella; Felice Esposito; Luigi Maria Cavallo; Paolo Cappabianca; Domenico Solari
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.